熊去氧胆酸用于原发性胆汁性肝硬化。 - Suppr

Suppr

超能文献

Ursodeoxycholic acid for primary biliary cirrhosis.

作者信息

Lindor K D, Poupon R, Poupon R, Heathcote E J, Therneau T

出版信息

Lancet. 2000 Feb 19;355(9204):657-8. doi: 10.1016/S0140-6736(05)72401-6.

DOI:10.1016/S0140-6736(05)72401-6

PMID:10697011

Abstract

摘要

相似文献

Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。

Lancet. 2000 Feb 19;355(9204):657-8. doi: 10.1016/S0140-6736(05)72401-6.

The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.熊去氧胆酸在原发性胆汁性肝硬化中的长期有益作用极具疑问。

Am J Gastroenterol. 2007 Feb;102(2):464-5. doi: 10.1111/j.1572-0241.2006.00904_15.x.

Primary biliary cirrhosis.原发性胆汁性肝硬化

N Engl J Med. 2005 Dec 22;353(25):2719-20; author reply 2719-20.

[Primary biliary cirrhosis and ursodeoxycholic acid therapy].[原发性胆汁性肝硬化与熊去氧胆酸治疗]

Nihon Naika Gakkai Zasshi. 1996 Mar 10;85(3):399-403.

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.熊去氧胆酸用于治疗原发性胆汁性肝硬化。

N Engl J Med. 2007 Oct 11;357(15):1524-9. doi: 10.1056/NEJMct074694.

Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.熊去氧胆酸与原发性胆汁性肝硬化的长期生存

Am J Gastroenterol. 2004 Feb;99(2):269-70.

Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.

J Hepatol. 2005 Mar;42(3):418-9. doi: 10.1016/j.jhep.2004.08.029.

Patients and patience: the pitfalls of primary biliary cirrhosis trials.患者与耐心：原发性胆汁性肝硬化试验的陷阱

Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):552-3. doi: 10.1038/ncpgasthep0360.

Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?熊去氧胆酸治疗原发性胆汁性肝硬化：对未来的启示？

J Hepatol. 2001 May;34(5):787-8. doi: 10.1016/s0168-8278(01)00061-7.

Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.

Hepatology. 2008 Apr;47(4):1428. doi: 10.1002/hep.22080.

引用本文的文献

Role of Lactoferrin in Treatment of Bile Duct Ligation-Induced Hepatic Fibrosis in Rats: Impact on Inflammation and TGF-β1/Smad2/α SMA Signaling Pathway.乳铁蛋白在大鼠胆管结扎诱导的肝纤维化治疗中的作用：对炎症和TGF-β1/Smad2/α-SMA信号通路的影响

J Clin Exp Hepatol. 2023 May-Jun;13(3):428-436. doi: 10.1016/j.jceh.2022.12.014. Epub 2022 Dec 29.

Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.原发性胆汁性胆管炎的药物干预：一项网状Meta分析尝试

Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011648. doi: 10.1002/14651858.CD011648.pub2.

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.尼曼-匹克C型病中细胞色素P450催化的药物代谢缺陷

PLoS One. 2016 Mar 28;11(3):e0152007. doi: 10.1371/journal.pone.0152007. eCollection 2016.

Primary biliary cirrhosis and liver transplantation.原发性胆汁性肝硬化与肝移植

Intractable Rare Dis Res. 2012 May;1(2):66-80. doi: 10.5582/irdr.2012.v1.2.66.

Primary biliary cirrhosis.原发性胆汁性肝硬化

Semin Immunopathol. 2009 Sep;31(3):283-307. doi: 10.1007/s00281-009-0164-5. Epub 2009 Jul 15.

Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population.55 岁或以上诊断为无症状原发性胆汁性肝硬化患者的死亡率与普通人群相似。

J Gastroenterol. 2009;44(9):1000-6. doi: 10.1007/s00535-009-0090-2. Epub 2009 Jun 27.

Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management.肝移植后复发性原发性胆汁性肝硬化——疾病及其管理

MedGenMed. 2006 May 3;8(2):30.

Ursodeoxycholic acid treatment of vanishing bile duct syndromes.熊去氧胆酸治疗肝内胆汁淤积症。

World J Gastroenterol. 2006 Jun 14;12(22):3487-95. doi: 10.3748/wjg.v12.i22.3487.

Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.复发性原发性胆汁性肝硬化：肝移植围手术期因素及肝移植后熊去氧胆酸治疗

Liver Transpl. 2005 Oct;11(10):1252-7. doi: 10.1002/lt.20511.

Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的医学治疗。

Clin Rev Allergy Immunol. 2005 Apr;28(2):135-45. doi: 10.1385/CRIAI:28:2:135.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验